See the full story in the original article.
Read the original on Yahoo Finance ↗
Related news
- Cathie Wood Bought CoreWeave Two Days in a Row as Its Bonds Cratered
ARK Invest bought 188,665 CoreWeave (NASDAQ:CRWV) shares on Wednesday and 192,566 more on Thursday, the same day CoreWeave's five-year credit default swaps hit a record intraday level of 1,194.5 basis points. The stock fell 15.46% to $65.78 on Wednesday, then rose 5.94% to $69.69 on Thursday, and is down 49.95% over the past year. The 9% notes due 2031 dropped to 79.9 cents on the dollar, lifting the yield to 15.6%, and the swap pricing implies a more than 60% chance of default within five years. With about $52 billion in debt and leases and a second-quarter net interest expense of $640 million that exceeded its $626 million net loss, the article argues that the credit picture calls for caution, since common shareholders are paid last.
- Cathie Wood’s ARK Buys CoreWeave. The Case for Buying Now.
- Nvidia CEO Jensen Huang will speak about CoreWeave's business when he wants to: Analyst
Analyst Tal Liani argues that Nvidia is financing deals with CoreWeave and other hyperscalers to block competition, ensuring they use Nvidia GPUs rather than AMD GPUs. CoreWeave stock fell 7% early Thursday after a 15% drop on Wednesday, as its corporate bonds were sold amid fears of an AI slowdown and concerns about its precarious balance sheet. The selling spread to other AI cloud stocks: Nebius fell 11%, Oracle dropped another 9%, and DigitalOcean, Hut 8, Cipher, TeraWulf and IREN each sank more than 10%. Nvidia invested $2 billion in CoreWeave earlier this year and now holds 47.2 million shares, around 10% of the company, while CoreWeave is also a major customer that buys Nvidia GPUs to rent out. As of the article, Huang had not commented on X or in an interview about the situation.
- Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.
Ark Invest founder Cathie Wood holds $379.1 million of CRISPR Therapeutics shares and bought $1.1 million on Oct. 9 and $2.3 million on Oct. 12 through the ARK Genomic Revolution ETF, even though the stock is down more than 25% over the past year. CRISPR's only approved therapy, Casgevy, posted $76 million in Q2 revenue, up 151% year over year, but its $2.2 million list price and the 60% revenue share going to Vertex limit its economics. The company's net loss narrowed to $91.2 million from $208.5 million, and it holds $2.36 billion in cash. The article also points to CTX-310, which cut LDL cholesterol by 53% and triglycerides by 48% after 12 months in a phase 1a trial, and to a phase 2 readout for blood thinner CTX611 expected later this year.
- Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Ark Investment Management, led by Cathie Wood, holds $220.4 million in Beam Therapeutics (BEAM) shares through its Ark ETFs, and recently bought another $2.8 million worth on Oct. 12 and 13 for the Ark Genomic Revolution (ARKG) fund. Beam develops gene-editing therapies using base editing, which changes single nucleotides without cutting both DNA strands, and its lead candidate, risto-cel, is in early trials for severe sickle cell disease. The company is far from profitable: first-half revenue was $32.2 million, up 50.5%, and loss per share was $2.09 versus $2.12 a year earlier, while $1.15 billion in cash is expected to fund operations through mid-2029. The stock is down more than 14% this year, and the article notes that the next 12 to 18 months will bring dense data readouts that could significantly lift the shares if positive.
- Cathie Wood-Led Ark Invest's Biggest Q3 Winners and Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged
Ark Invest's Q3 report shows 10x Genomics (TXG) was the standout winner, adding 9.03 points to ARKG's 28.92% gain, driven by interest in single-cell sequencing for AI drug-discovery data. Twist Bioscience (TWST, up 87.83%) and Tempus AI (TEM, up 41.38%) also contributed strongly, while Palantir (PLTR) boosted several ETFs. Tesla (TSLA) was the most consistent drag, subtracting 1.72 points from ARKQ and 1.75 points from ARKK after weak second-quarter profitability, although the stock recovered as it launched Cybercab and passed 1 million unsupervised robotaxi miles. Rocket Lab (RKLB) also weighed on space-focused funds, subtracting 2.04 points from ARKX. ARKK fell nearly 5% in Friday's regular session.
Related markets
Latest news
- Meta Earnings: What To Look For From META
Meta Platforms (NASDAQ:META) will report earnings this Wednesday after the market closes. Last quarter, revenue reached $60.8 billion, up 28% year on year and above analysts' expectations, though revenue guidance for next quarter slightly missed forecasts; daily active users hit 3.6 billion, up 3.4%. The market expects revenue growth of 23.6% this quarter, slowing from 26.2% a year earlier, and analysts have generally reconfirmed their estimates over the past 30 days. Over the last month, consumer internet stocks have gained 1.3% on average, while Meta is down 4.8%.
- An AI bust could come from places investors arent watching , an economist says
Concerns about an AI bubble are growing, and TS Lombard's Dario Perkins warns that investors may be overlooking other risks. Debt among smaller cloud providers, model developers and suppliers could reach $2 trillion by the end of 2027. Perkins does not see this as a systemic risk, but warns that earnings disappointments and canceled orders could ripple through the ecosystem, and that a chip glut could follow over-ordering. Much of the industry's revenue growth still comes from spending within the AI ecosystem rather than from businesses and consumers outside it. He also flags political backlash, noting that ordinary people dislike AI and nearby datacenters, and warns that one high-profile accident could turn AI toxic.
- Yen jumps after JGB auction draws big demand , euro finds relief
The yen rose 0.2% to 158.15 per dollar in Asian trading after a 20-year Japanese government bond auction drew bids of 5.84 times the amount sold, well above the 4.01 times at the previous auction, and the yield fell 6 basis points to 3.71%. A State Street strategist said the record demand suggests sidelined cash is returning and that JGBs are becoming a relative haven from political and fiscal volatility in Europe, particularly France. Anti-government protests in France prompted curfews in several cities, while Italy said it would send 500 troops after two days of unrest, and the euro rallied 0.2% to $1.1234. Elsewhere, bitcoin slipped 0.3% to $81,674.25 and ether edged down 0.2% to $2,393.21.
- Unemployment rate dips to 4 . 7 % - but vacancies hit five - year low
Vacancies fell by 21,000 to 691,000 in the three months to September, the biggest drop since the three months to March and the lowest since July to September 2014 outside the pandemic, while unemployment dipped in the three months to August. Payroll numbers were down 66,000 over the year to September. The ONS said the fall was mainly among smaller firms struggling with higher labour costs, following rises in employer national insurance, the minimum wage and workers' rights. A CBI survey found labour costs and regulations were making it harder to create jobs, and firms urged the Chancellor not to add to their burden in the October 28 Budget. ICAEW's Suren Thiru said the labour market is 'running on idle' and unemployment could climb above 5 per cent, while Shadow Chancellor Andrew Griffith blamed Labour's 'Jobs Tax' and red tape.
- CNBC Daily Open: Tech rebounds in the U.S., but Asia isn’t buying it yet
U.S. tech stocks rebounded as the Nasdaq Composite rose more than 1% on Monday, with Nvidia up 1.4% and Tesla up 3.8%. In Asia, however, tech shares fell on Tuesday, with South Korea's Kospi down over 4% and Japan's Nikkei 225 down 1.6%. Nvidia also unveiled plans to back four German AI startups as part of its nearly $10 billion European investment commitment. Jenny Lee of Granite Asia said Asian companies are reaching IPOs much sooner, often at four to five years old, while Jio Platforms' Indian IPO saw its anchor investor quota oversubscribed more than 30 times, aiming to raise up to 302 billion rupees ($3.2 billion). In Singapore, several agricultural stocks fell after Senior Minister K Shanmugam warned that companies would not escape responsibility for possible roles in the haze, noting seven firms had been questioned by the Singapore Exchange.
- NiSource (NI) Stock Looks Overvalued Against Its Dividend Outlook
NiSource has nearly doubled shareholders' money over the past five years, delivering a 97.6% total return, which raises the question of whether dividends can justify the current share price. The article highlights a new 20-year energy agreement with Microsoft, including customer-funded grid upgrades and long-term electric service for data centers, which may affect future capital needs and cash-flow visibility. Using a Dividend Discount Model with inputs of about $1.35 dividend per share, roughly 9.07% return on equity, a payout ratio slightly above 61%, and implied dividend growth of about 3.5%, the estimated intrinsic value sits meaningfully below the current share price of $41.95. The model still does not bridge that gap, suggesting income investors are paying a premium for a relatively steady payout with modest assumed growth.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.